Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Breast cancer
Age: Adult
Dose: Intravenous – 60-100 mg/m2
Frequency: once every 3 weeks
Duration: infusion over 1 hour
Indication: Breast cancer
Age: Adult
Condition: In combination with doxorubicin or capecitabine or as adjuvant therapy with doxorubicin and cyclophosphamide
Dose: Intravenous – 75 mg/m2
Frequency: once every 3 weeks

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: Not applicable – No approved dosage
Note: No approved pediatric dosage available

Renal Dose

Clinical InformationAdministration Information
Condition: Renal Impairment
Dose: Renal Impairment – Dose adjustment not necessary
Note: Renal impairment dose adjustment not necessary
Administration
  • Hospital administration only
  • Given via IV infusion
Side Effect

Drug Interaction

Drug NameRisk Factors
CYP3A4 inducers, inhibitors, or substrates
May alter docetaxel metabolism

Disease Interaction

Disease NameRisk Factors
Severe Neutropenia
Risk of infection
Severe Liver Impairment
Can worsen liver function

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store between 2°C and 25°C and protected from light. Freezing does not adversely affect the product.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.